Saturday, April 15, 2017 2:02:31 PM
April 11, 2017 /PRNewswire/ --
Encompass Compliance Corp. (OTC PINK: ENCC), signed an agreement that allows them to provide compliance services to DATIA members. On 16th-18th May, DATIA has its annual conference and Encompass Compliance Corp. will be a featured speaker focusing on the challenges and nuances for drug testing rules in the workplace.
DATIA's members provide drug testing products and services to over 1,000,000 (million) corporations throughout the U.S. These members provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. "Many of the major service and product suppliers to corporate America are members of DATIA. Therefore, we have a great audience to provide our Risk Shield Compliance services in support of our partner, DATIA," says Encompass CEO, Richard Sharp.
_______________________________________________________
100.000 x $25 per month = $2.500.000 per month
- Only with this potential client.
April 4, 2017 /PRNewswire/ --
Encompass Compliance Corp. (OTC PINK: ENCC) has compiled critical data of the savings, by a fortune 500 Customer that has over 100,000 employees in the U.S.
This respective company conducted a 6-state pilot implementing Encompass Compliance Corporation's Risk Shield services and "the results were amazing," said the customer. After just 6 months, the company's drug and alcohol claims were reduced 20%, resulting in a $6.5 million savings on claim pay outs.The results were so impressive they have decided to expand the program to more states.
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM